Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-22-000082
Filing Date
2022-12-15
Accepted
2022-12-15 16:26:39
Documents
1
Period of Report
2022-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167113958127044.html 4  
1 FORM 4 wf-form4_167113958127044.xml 4 3219
  Complete submission text file 0001824293-22-000082.txt   4620
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Issuer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1226 CHARTER LANE AMBLER PA 19002
Business Address
Thorell Marella (Reporting) CIK: 0001826323 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 221465127